SENATE DOCKET, NO. 1813        FILED ON: 1/20/2017

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1102

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

John F. Keenan

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act to expand addiction treatment within houses of correction.

_______________

PETITION OF:

 

Name:

District/Address:

 

John F. Keenan

Norfolk and Plymouth

 

Michael G. Bellotti, Norfolk County Sheriff

200 West St., Dedham, MA 02127

 

Adam G. Hinds

Berkshire, Hampshire, Franklin and Hampden

2/1/2017

Carlos González

10th Hampden

2/3/2017


SENATE DOCKET, NO. 1813        FILED ON: 1/20/2017

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1102

By Mr. Keenan, a petition (accompanied by bill, Senate, No. 1102) of John F. Keenan, Michael G. Bellotti, Norfolk County Sheriff, Adam G. Hinds and Carlos Gonzalez for legislation to expand addiction treatment within houses of correction.  Mental Health, Substance Use and Recovery.

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninetieth General Court
(2017-2018)

_______________

 

An Act to expand addiction treatment within houses of correction.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1.  Subject to appropriation, the department of public health, in consultation with the bureau of substance abuse services and the Massachusetts Sheriffs’ Association, shall create an extended-release injectable naltrexone pilot program for individuals with opioid or alcohol addiction in houses of correction. The purpose of the program shall be to facilitate, through grant funding to at least two county sheriffs’ offices, multiple administrations of extended-release injectable naltrexone in series to persons with upcoming release dates, beginning not less than 6 months prior to their release. The department shall collect outcomes data for such programs on an ongoing basis, in a manner substantially similar to the data collection described in section 158 of chapter 46 of the acts of 2015.